Current Oncology (Oct 2024)

Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers

  • Anna Fischl,
  • Michael Gerken,
  • Patricia Lindberg-Scharf,
  • Tareq M. Haedenkamp,
  • Katharina Rosengarth,
  • Andrea Hillberg,
  • Martin Vogelhuber,
  • Ingrid Schön,
  • Martin Proescholdt,
  • Tommaso Araceli,
  • Michael Koller,
  • Anne Herrmann,
  • Oliver Kölbl,
  • Tobias Pukrop,
  • Markus J. Riemenschneider,
  • Nils Ole Schmidt,
  • Monika Klinkhammer-Schalke,
  • Ralf Linker,
  • Peter Hau,
  • Elisabeth Bumes

DOI
https://doi.org/10.3390/curroncol31100459
Journal volume & issue
Vol. 31, no. 10
pp. 6155 – 6170

Abstract

Read online

(1) Background: Clinical aspects like sex, age, Karnofsky Performance Scale (KPS) and psychosocial distress can affect the health-related quality of life (HR-QoL) and treatment satisfaction of patients with malignant isocitrate dehydrogenase wild-type (IDHwt) gliomas and caregivers. (2) Methods: We prospectively investigated the HR-QoL and patient/caregiver treatment satisfaction in a cross-sectional study with univariable and multiple regression analyses. Questionnaires were applied to investigate the HR-QoL (EORTC QLQ-C30, QLQ-BN20) and treatment satisfaction (EORTC PATSAT-C33). (3) Results: A cohort of 61 patients was investigated. A higher KPS was significantly associated with a better HR-QoL regarding the functional scales of the EORTC QLQ-C30 (p p p = 0.010). None of the investigated aspects showed a significant impact on the treatment satisfaction of caregivers. (4) Conclusions: We demonstrated that in patients with IDHwt gliomas, the KPS was the most important predictor for a better HR-QoL in functional domains. Data on the HR-QoL and treatment satisfaction in patients with IDHwt gliomas and their caregivers are rare; therefore, further efforts should be made to improve supportive care in this highly distressed cohort.

Keywords